These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18666394)

  • 21. Efficacy, Safety, and Tolerability of 4% 5-Fluorouracil Cream in a Novel Patented Aqueous Cream Containing Peanut Oil Once Daily Compared With 5% 5-Fluorouracil Cream Twice Daily: Meeting the Challenge in the Treatment of Actinic Keratosis.
    Dohil MA
    J Drugs Dermatol; 2016 Oct; 15(10):1218-1224. PubMed ID: 27741339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head.
    Stockfleth E; Sterry W; Carey-Yard M; Bichel J
    Br J Dermatol; 2007 Dec; 157 Suppl 2():41-6. PubMed ID: 18067631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
    Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
    Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies.
    Gupta AK; Davey V; Mcphail H
    J Cutan Med Surg; 2005 Oct; 9(5):209-14. PubMed ID: 16502198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp.
    Smith SR; Morhenn VB; Piacquadio DJ
    J Drugs Dermatol; 2006 Feb; 5(2):156-9. PubMed ID: 16485883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).
    Nelson C; Rigel D; Smith S; Swanson N; Wolf J
    J Drugs Dermatol; 2004; 3(4):401-7. PubMed ID: 15303784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical photodynamic therapy of actinic keratosis in renal transplant recipients.
    Piaserico S; Belloni Fortina A; Rigotti P; Rossi B; Baldan N; Alaibac M; Marchini F
    Transplant Proc; 2007; 39(6):1847-50. PubMed ID: 17692630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy and safety of topical 5% 5-fluorouracil in renal transplant recipients for the treatment of actinic keratoses.
    Ingham AI; Weightman W
    Australas J Dermatol; 2014 Aug; 55(3):204-8. PubMed ID: 24627952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials.
    Lebwohl M; Dinehart S; Whiting D; Lee PK; Tawfik N; Jorizzo J; Lee JH; Fox TL
    J Am Acad Dermatol; 2004 May; 50(5):714-21. PubMed ID: 15097955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of actinic keratoses with a combination of 5-fluorouracil and imiquimod creams.
    Price NM
    J Drugs Dermatol; 2007 Aug; 6(8):778-81. PubMed ID: 17763606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head.
    Alomar A; Bichel J; McRae S
    Br J Dermatol; 2007 Jul; 157(1):133-41. PubMed ID: 17501955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensity of Local Skin Reactions During 5-Fluorouracil Treatment Related to the Number of Actinic Keratosis Lesions: A Post Hoc, Exploratory Analysis.
    Stockfleth E; Bégeault N; Delarue A
    Dermatol Ther (Heidelb); 2022 Feb; 12(2):467-479. PubMed ID: 34954811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twice daily vs. four times daily 5-fluorouracil therapy for actinic keratoses: a split face study.
    Epstein E
    Br J Dermatol; 2006 Apr; 154(4):794-5. PubMed ID: 16536841
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of pyruvic acid in the treatment of actinic keratoses: a clinical and histopathologic study.
    Griffin TD; Van Scott EJ
    Cutis; 1991 May; 47(5):325-9. PubMed ID: 2070654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses.
    Lawrence N; Cox SE; Cockerell CJ; Freeman RG; Cruz PD
    Arch Dermatol; 1995 Feb; 131(2):176-81. PubMed ID: 7857114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel 0.5% fluorouracil cream is minimally absorbed into the systemic circulation yet is as effective as 5% fluorouracil cream.
    Levy S; Furst K; Chern W
    Cutis; 2002 Aug; 70(2 Suppl):14-21. PubMed ID: 12353676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical treatment of actinic keratoses with low-dose 5-fluorouracil in combination with salicylic acid--pilot study.
    Schlaak M; Simon JC
    J Dtsch Dermatol Ges; 2010 Mar; 8(3):174-8. PubMed ID: 19889001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses.
    Stockfleth E; Meyer T; Benninghoff B; Salasche S; Papadopoulos L; Ulrich C; Christophers E
    Arch Dermatol; 2002 Nov; 138(11):1498-502. PubMed ID: 12437457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facial resurfacing for nonmelanoma skin cancer prophylaxis.
    Hantash BM; Stewart DB; Cooper ZA; Rehmus WE; Koch RJ; Swetter SM
    Arch Dermatol; 2006 Aug; 142(8):976-82. PubMed ID: 16924046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.